Christopher Mutz

Christopher Mutz

Corporate Officer/Principal at ANI PHARMACEUTICALS, INC.

Net worth: 5 M $ as of 2026-05-30

55 year
Health Technology
Consumer Services

Profile

Christopher K.
Mutz
is Senior Vice President & Head-Rare Diseases at ANI Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Mutz was National Sales Director-US Metabolic Business Unit at Alexion Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Virginia and an MBA from Johnson Graduate School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-15 62,245 ( 0.27% ) 5 M $ 2026-05-30

Christopher Mutz active positions

CompaniesPositionStart
ANI PHARMACEUTICALS, INC. Corporate Officer/Principal 2021-02-16

Former positions of Christopher Mutz

Training of Christopher Mutz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

6

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Health Technology

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Christopher Mutz